Sagimet Biosciences Inc. Lessee, Operating Lease, Liability, to be Paid in USD from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Sagimet Biosciences Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q4 2022 to Q4 2024.
  • Sagimet Biosciences Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending December 31, 2024 was $80K, a 21.2% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)

Sagimet Biosciences Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $80K +$14K +21.2% Dec 31, 2024 10-K 2025-03-12
Q4 2023 $66K -$171K -72.2% Dec 31, 2023 10-K 2024-03-25
Q3 2023 $106K Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $145K Jun 30, 2023 10-Q 2023-08-21
Q4 2022 $237K Dec 31, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.